Toggle menu

DEUCE

Start date:
Historic
End date:
July 2012
Co-ordinated by:
NHS Lothian

Is Rotational Thromboelastometry (ROTEM) useful to detect Occult Coagulopathy in the Emergency Department?

Aim

  • To see whether rotational thromboelastometry (ROTEM) is useful to detect occult coagulopathy in bleeding ED patients.
  • To see what proportion of patients presenting to the ED with bleeding conditions have a coagulopathy on arrival and whether this is sufficient to warrant routine ROTEM use in the ED.
  • To see what proportion of patients presenting to the ED with bleeding conditions develop a coagulopathy during their ED stay, and whether this is sufficient to warrant routine ROTEM use in the ED.
  • To see whether ED staff can be trained to use ROTEM and whether the knowledge is retained.

Trial Design

Single-centre, prospective, observational cohort study,  conducted in the Emergency Department (ED) of the Royal Infirmary of Edinburgh.

List of Publications – references

Reed MJ, Nimmo AF, McGee D, Manson L, Neffendorf AE, Moir L, Donaldson LS. Rotational thrombolelastometry produces potentially clinical useful results within 10 min in bleeding Emergency Department patients: the DEUCE study. Eur J Emerg Med. 2013; 20(3): 160-6

Chief Investigator

Dr Matt Reed

Consultant and NRS Career Research Fellow in Emergency Medicine

Local PI

Dr Matt Reed

Consultant and NRS Career Research Fellow in Emergency Medicine

More EMERGE Trials

Patients commonly present to the Emergency Department with epistaxsis (nose bleed). Standard first aid measures such as applying pressure can often stem bleeding however in more severe cases of epistaxsis further treatment is required.

Read more

NoPac

Novel Use of Tranexamic Acid to Reduce the Need for Nasal Packing

Detection of physiological deterioration by the SNAP40 wearable device compared to standard monitoring devices in the Emergency Department

Read more

SNAP40

Evaluating the role of ambulatory, wireless vital sign monitoring in the detection of deterioration

This trial is a two arm, multicentre parallel group, randomised controlled, open label trial comparing intravenous levetiracetam to intravenous phenytoin for the treatment of convulsive status epilepticus (CSE) in children, young people and young adults.

Read more

EcLiPSE

Emergency Treatment with Levetiracetam or Phenytoin in Status Epilepticus in Children (EcLiPSE) – an open label randomised controlled trial